$SOPAQ Cashflow Statement | Understand Stock

$SOPAQ

$0.00 -$0.00 (33.33%) Close

$SOPAQ Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Impairment loss
Imputed interest
Loss on settlement of litigation
Warrant modification expense (non-cash)
Bad debts
Depreciation and amortization
Gain from early lease termination
Written-off of plant and equipment
Written-off of intangible assets
Gain on disposal of plant and equipment
Write-off of plant and equipment
Impairment loss of intangible assets
Impairment loss of goodwill
Loss on disposal of a subsidiary
Waiver of loan payable
Financing charges – first insurance funding
Treasury stock
Stock based compensation for services
Deferred tax assets

Change in operating assets and liabilities:
Accounts receivable
Inventories
Deposits, prepayments and other receivables
Contract assets
Contract liabilities
Accounts payables
Advances to related parties
Accrued liabilities and other payables
Due to related parties
Right of use assets
Operating lease liabilities
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchase of property, plant, and equipment
Purchase of investment assets
Purchase of intangible assets
Purchase of plant, and equipment
Purchase of subsidiary
Purchase of assets in a business operation
Cash from purchase of subsidiary and business operation
Net cash used in investing activities
Cash flows from financing activities:
Proceed from the issuance of preferred stock and exercise of warrants into preferred stock
Proceeds from initial public offering, net of offering expenses
Repayment of loan
Proceeds from private placements
Proceeds from loans
Repayment of loans
Repurchase of common share
Proceed from the sale of treasury stock
Net cash provided by (used in) financing activities
Effect on exchange rate change on cash and cash equivalents
NET CHANGE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENT AT BEGINNING OF YEAR
CASH AND CASH EQUIVALENT AT END OF YEAR
Supplemental disclosure of cash flow information:
Cash paid for interest
Impact of adoption of ASC Topic 842 - lease obligation and ROU asset
Waiver of related party debt accounted as capital transaction
Fair value of preferred stock issued for services
Fair value of preferred stock accounted and included for issuance cost
Common stock issued for accrued salaries
Shares cancellation
Prepaid insurance financed by first insurance funding
Common stock issued for the conversion of preferred stock
Derecognized lease ROU assets and lease liability on early termination
Cash paid for income tax
Reconciliation to amounts on audited consolidated balance sheets:
Cash and cash equivalents
Restricted cash
Total cash, cash equivalents and restricted cash
Shares issued to acquire subsidiary
Shares issued to acquire business operation
Shares issued for accrued services
Impact of adoption of ASC 842 - lease obligation and ROU asset
NON-CASH INVESTING AND FINANCING ACTIVITIES
Shares issued to acquire subsidiary

Comments